Related Experiment Video
Updated: Jan 8, 2026
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Factors associated with respiratory syncytial virus vaccination among Japanese adults aged 60 years and older: an
Shingo Noguchi1, Tomohiro Ishimaru2, Kazuhiro Yatera3
1Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan; Department of Respiratory Medicine, Tobata General Hospital, Japan.
Background:
Respiratory syncytial virus (RSV) is a common pathogen in young children and older adults. Recently, RSV vaccines have been approved in adults aged 60 years and older and have demonstrated substantial efficacy. However, limited data on older adults receiving the RSV vaccination are available. We aimed to identify potential factors associated with RSV vaccination among adults aged 60 years and older.
Methods:
Data from 28,000 respondents of the Japan COVID-19 and Society Internet Survey 2024 were used, and data from participants aged 60 years and older were extracted. The association between RSV vaccination status and potential factors (age, sex, marital status, living status, household income, education, working status, comorbidities, COVID-19/influenza vaccination status, and knowledge about RSV and its vaccine) was evaluated using univariate and multivariate analyses.
Results:
We included 8300 participants, of whom 349 (4.2 %) received the RSV vaccine. After adjustment, older age (age group "80-84" years, adjusted odds ratio [aOR]: 3.79, 95 % confidence interval [CI]: 2.43-5.92), living with two or more people (aOR: 1.63, 95 % CI: 1.03-2.57), diabetes (aOR: 1.59, 95 % CI: 1.20-2.11), stroke (aOR: 2.29, 95 % CI: 1.29-4.06), chronic obstructive pulmonary disease (aOR: 3.00, 95 % CI: 1.67-5.38), and COVID-19 (aOR: 2.38, 95 % CI: 1.81-3.12) and influenza vaccination (aOR: 2.03, 95 % CI: 1.60-2.57) were significantly associated with an increase in RSV vaccination rates. Additionally, higher vaccination rates were associated with higher knowledge of the clinical picture (aOR: 2.37, 95 % CI: 1.89-2.97), disease severity (aOR: 3.50, 95 % CI: 2.80-4.38), and vaccine eligibility (aOR: 5.75, 95 % CI: 4.58-7.22).
Conclusions:
RSV vaccination was more prevalent among older adults in certain high-risk groups. However, overall coverage remains low, and further efforts are needed for educational and awareness initiatives.
Related Concept Videos
01:18Factors Affecting Illness
For instance, risk factors are connected to illness,...
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:19Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
01:31Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
01:28Physical Assessment of the Respiratory Tract I: Health History
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History